NCT00434629
- Conditions
- B-cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
- Locations
-
- Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States
Clinical trial condition
Lymphoma, Non-Hodgkin
Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.
1,630 public trials
214 recruiting studies
Lymphoma, Non-Hodgkin trial results
NCT00117156
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- University of Rochester Cancer Center Rochester, New York, United States
NCT00133367
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Graft vs Host Disease, +27 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
NCT02559583
- Conditions
- Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +25 more
- Locations
-
- Buenos Aires, Argentina
- Córdoba, Argentina
- La Plata Lpl Lpl, Argentina
- Belo Horizonte, Brazil
NCT00533923
- Conditions
- ALL, AML, Anemia, +34 more
- Locations
-
- Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
NCT00006252
- Conditions
- Chronic Disease, Disease Attributes, Hematologic Diseases, +20 more
- Locations
-
- Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
- Veterans Affairs Medical Center - San Diego San Diego, California, United States
- UCSF Comprehensive Cancer Center San Francisco, California, United States
- Beebe Medical Center Lewes, Delaware, United States
NCT02018874
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
- Locations
-
- Gustave Roussy Villejuif, Val de Marne, France
Completed
Study of IPI-145 in Combination With Rituximab or Bendamustine/Rituximab in Hematologic Malignancies
NCT01871675
- Conditions
- Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +22 more
- Locations
-
- The Colorado Blood Cancer Institute Denver, Colorado, United States
- Florida Cancer Specialists Sarasota, Florida, United States
- Oklahoma University Oklahoma City, Oklahoma, United States
- Tennessee Oncology, PLLC Nashville, Tennessee, United States
NCT00003863
- Conditions
- Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +17 more
- Locations
-
- Northeast Alabama Regional Medical Center Anniston, Alabama, United States
- Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
- Naval Medical Center - San Diego San Diego, California, United States
- Veterans Affairs Medical Center - San Diego San Diego, California, United States
Completed
Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
NCT00062114
- Conditions
- Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
- Locations
-
- Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- Providence Saint Joseph Medical Center - Burbank Burbank, California, United States
- Moores UCSD Cancer Center La Jolla, California, United States
- Kaiser Permanente Medical Office -Vandever Medical Office San Diego, California, United States